RecruitingACTRN12611000504910

A prospective longitudinal cohort study describing quality of life in patients undergoing pulmonary metastasectomy for metastatic sarcoma

Sponsor

Australasian Sarcoma Study Group (ASSG)

Enrollment

140 participants

Start Date

Apr 20, 2011

Study Type

Observational

Conditions

To evaluate the health-related quality of life (HRQOL) associated with pulmonary metastasectomy (PM) from metastatic sarcoma

Summary

Evaluate the Health Related Quality of Life (HRQOL) associated with pulmonary metastasectomy (PM) (specifically: dyspnoea, cough, chest pain, pain interference, fatigue, physical functioning, role functioning, social functioning, satisfaction with social discretionary activities and satisfaction with social roles, emotional functioning, depression, anxiety and overall HRQOL).

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria5

Metastatic bone or soft tissue sarcoma
Lung-only metastases
Planned pulmonary metastasectomy
Age greater than or equal to 18 years
Signed informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

No intervention, Quality of Life Study. Patients undergoing a PM for metastatic sarcoma will be invited to complete HRQOL Assessments prior to their surgery and at certain time points after their sur

No intervention, Quality of Life Study. Patients undergoing a PM for metastatic sarcoma will be invited to complete HRQOL Assessments prior to their surgery and at certain time points after their surgery for up to three years after their PM surgery.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000504910